Meeting
2018 ASCO-SITC Clinical Immuno-Oncology Symposium
Safety and feasibility of immuno-cryotherapy.
Authors
Junaid Raja
Yale University, New Haven, CT
Junaid Raja, Anish Ghodadra, Scott N. Gettinger, Harriet M. Kluger, Mario Sznol, Kurt Alex Schalper, Hyun S. "Kevin" Kim
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B
Track
Developmental Therapeutics,Genitourinary Cancer,Head and Neck Cancer,Lung Cancer,Melanoma/Skin Cancers,Gastrointestinal Cancer,Breast and Gynecologic Cancers,Combination Studies,Implications for Patients and Society,Miscellaneous Cancers,Oncolytic Viruses,Hematologic Malignancies
Sub Track
Immune Checkpoints and Stimulatory Receptors
Citation
J Clin Oncol 36, 2018 (suppl 5S; abstr 34)
DOI
10.1200/JCO.2018.36.5_suppl.34
Abstract #
34
Poster Bd #
D2
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Annual Meeting
The efficacy of immune checkpoint inhibitors and PD-L1 status in patients with advanced non-small cell lung cancer harboring oncogenic driver alterations: Immuno-oncology biomarker study in LC-SCRUM-Japan.
First Author: Kiyotaka Yoh
Poster
2018 ASCO-SITC Clinical Immuno-Oncology Symposium
Efficacy of immune-checkpoint inhibitors (ICI) in non-small cell lung cancer (NSCLC) patients harboring activating molecular alterations.
First Author: Laurent Mhanna
Poster
2014 ASCO Annual Meeting
Safety and clinical activity of MK-3475 in previously treated patients (pts) with non-small cell lung cancer (NSCLC).
First Author: Edward B. Garon
Poster
2014 ASCO Annual Meeting
PD-L1 expression and genotype in non-small cell lung cancer (NSCLC).
First Author: Sascha Ansen